COMT Val158Met polymorphism is associated with post-traumatic stress disorder and functional outcome following mild traumatic brain injury

Author(s): Winkler EA, Yue JK, Ferguson AR, Temkin NR, Stein MB, et al.

Abstract

Mild traumatic brain injury (mTBI) results in variable clinical trajectories and outcomes. The source of variability remains unclear, but may involve genetic variations, such as single nucleotide polymorphisms (SNPs). A SNP in catechol-o-methyltransferase (COMT) is suggested to influence development of post-traumatic stress disorder (PTSD), but its role in TBI remains unclear. Here, we utilize the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study to investigate whether the COMT Val158Met polymorphism is associated with PTSD and global functional outcome as measured by the PTSD Checklist – Civilian Version and Glasgow Outcome Scale Extended (GOSE), respectively. Results in 93 predominately Caucasian subjects with mTBI show that the COMT Met158 allele is associated with lower incidence of PTSD (univariate odds ratio (OR) of 0.25, 95% CI [0.09–0.69]) and higher GOSE scores (univariate OR 2.87, 95% CI [1.20–6.86]) 6-months following injury. The COMT Val158Met genotype and PTSD association persists after controlling for race (multivariable OR of 0.29, 95% CI [0.10–0.83]) and pre-existing psychiatric disorders/substance abuse (multivariable OR of 0.32, 95% CI [0.11–0.97]). PTSD emerged as a strong predictor of poorer outcome on GOSE (multivariable OR 0.09, 95% CI [0.03–0.26]), which persists after controlling for age, GCS, and race. When accounting for PTSD in multivariable analysis, the association of COMT genotype and GOSE did not remain significant (multivariable OR 1.73, 95% CI [0.69–4.35]). Whether COMT genotype indirectly influences global functional outcome through PTSD remains to be determined and larger studies in more diverse populations are needed to confirm these findings.

Similar Articles

The structure of PTSD symptoms according to DSM-5 and IDC-11 proposal: A multi-sample analysis

Author(s): Cyniak Cieciura M, Staniaszek K, Popiel A, Praglowska E, Zawadzki B, et al.

Pharmacology for sleep disturbance in PTSD

Author(s): Lipinska G, Baldwin DS, Thomas KG

PTSD symptoms, demographic characteristics, and functional status among veterans treated in VA primary care clinics

Author(s): Magruder KM, Frueh BC, Knapp RG, Johnson MR, Vaughan JA, et al.

The effect of draft DSM-V criteria on posttraumatic stress disorder prevalence

Author(s): Calhoun PS, Hertzberg JS, Kirby AC, Dennis MF, Hair LP, et al.

National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria

Author(s): Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, et al.

Gender differences in substance abuse, PTSD and intentional self-harm among veterans health administration patients

Author(s): Gradus JL, Leatherman S, Curreri A, Myers LG, Ferguson R, et al.

Mild traumatic brain injury in U

Author(s): Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, et al.

Blast-related traumatic brain injury

Author(s): Rosenfeld JV, McFarlane AC, Bragge P, Armonda RA, Grimes JB, et al.

Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder

Author(s): Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW, et al.

Neurobiology of posttraumatic stress disorder

Author(s): Heim C, Nemeroff CB

A users guide to HPA axis research

Author(s): Spencer RL, Deak T

PTSD and gene variants new pathways and new thinking

Author(s): Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley Davino B, et al.

  Glucocorticoid receptor polymorphisms and post-traumatic stress disorder

Author(s): Bachmann AW, Sedgley TL, Jackson RV, Gibson JN, Young RM, et al.

Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults

Author(s): White S, Acierno R, Ruggiero KJ, Koenen KC, Kilpatrick DG,  et al.

Increased CSF cortisol in AD is a function of APOE genotype

Author(s): Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA, et al.

Effect Of The APOE epsilon4 Allele And Combat Exposure On PTSD Among Iraq/Afghanistan-Era Veterans

Author(s): Kimbrel NA, Hauser MA, Garrett M, Ashley Koch A, Liu Y, et al.

Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure

Author(s): Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, et al.

The ankyrin-3 gene is associated with posttraumatic stress disorder and externalizing comorbidity

Author(s): Logue MW, Solovieff N, Leussis MP, Wolf EJ, Melista E, et al.

The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans

Author(s): Voisey J, Swagell CD, Hughes IP, Morris CP, van Daal A, et al.

Glucocorticoid receptors in depression relationship to the dexamethasone suppression test

Author(s): Gormley GJ, Lowy MT, Reder AT, Hospelhorn VD, Antel JP, et al.

Glucocorticoid receptors and depression

Author(s): Whalley LJ, Borthwick N, Copolov D, Dick H, Christie JE,  et al.

Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder

Author(s): Yehuda R, Kahana B, Binder Brynes K, Southwick SM, Mason JW,  et al.

Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis

Author(s): Johnson EO, Kamilaris TC, Chrousos GP, Gold PW

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder

Author(s): Kosten TR, Mason JW, Giller EL, Ostroff RB, Harkness L, et al.

Noradrenergic dysregulation in the pathophysiology of PTSD

Author(s): Hendrickson RC, Raskind MA

The neurobiology of PTSD implications for nurses

Author(s): Olszewski TM, Varrasse JF

The cardiovascular toll of stress

Author(s): Brotman DJ, Golden SH, Wittstein IS

Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder

Author(s): Von Kanel R, Hepp U, Kraemer B, Traber R, Keel M, et al.

PTSD NCf Overview of Psychotherapy for PTSD

Author(s): Norman S, Hamblen J, Paula P. Schnurr, Eftekhari A, et al.

Review of exposure therapy: a gold standard for PTSD treatment

Author(s): Rauch SA, Eftekhari A, Ruzek JI

PTSD and TBI co-morbidity: scope, clinical presentation and treatment options

Author(s): Tanev KS, Pentel KZ, Kredlow MA, Charney ME

Classical fear conditioning in the anxiety disorders: a meta-analysis

Author(s): Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, et al.

Deep brain stimulation: indications and evidence

Author(s): Pereira EA, Green AL, Nandi D, Aziz TZ

Amygdala deep brain stimulation is superior to paroxetine treatment in a rat model of posttraumatic stress disorder

Author(s): Stidd DA, Vogelsang K, Krahl SE, Langevin JP, Fellous JM, et al.

MRI uncovers disrupted hippocampal microstructure that underlies memory impairments after early-life adversity

Author(s): Molet J, Maras PM, Kinney Lang E, Harris NG, Rashid F, et al.

MicroRNAs in Post-traumatic Stress Disorder

Author(s): Snijders C, de Nijs L, Baker DG, Hauger RL, van den Hove D, et al.

DICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression

Author(s): Wingo AP, Almli LM, Stevens JS, Klengel T, Uddin M, et al.

Hyperbaric oxygen therapy in the battlefield

Author(s): Verghese G, Verma R, Bhutani S